Induction of human cytotoxic T cells by peptide-pulsed universal antigen presenting cells

肽脉冲通用抗原呈递细胞诱导人细胞毒性 T 细胞

基本信息

  • 批准号:
    16390294
  • 负责人:
  • 金额:
    $ 9.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2006
  • 项目状态:
    已结题

项目摘要

We examined the presence of EB virus (EBV) specific cytotoxic T cells, induction of EBV specific CTLs and the cytotoxic activities of induced CTLs in the peripheral CD8+ cells from the patient with chronic active EBV infection (CAEBV) and the results were as follows,1.Demonstration of EBV specific CTLs by HLAA24-specific and EBV-specific tetramer analysisBRLF1 peptides specific CTLs were found in the peripheral lymphocytes of healthy volunteers and those of patients with infectious mononucleosis. Interestingly, we were also able to demonstrate BRLF1 peptides specific CTLs in the peripheral blood of the patients with CAEBV.2.Induction of antigen specific CTLs :We used HLAA24 positive autologous B lymphobastoid cells (B-LCLs) as antigen presenting cells and peripheral mononuclear cells were stimulated with B-LCLs, pulsed with or without BRLF1 peptide. We were successfully able to induce BRLF1 tetramer positive CTLs even in the absence of BRLF1 specific peptides. This suggested that enoug … More h BRLF1 specific stimulation were given from the EBV infected B-LCLs to specific CTLs without further peptide pulse. These CD8 positive BRLF1 tetramer specific induction and proliferation of CTLs were observed in the mononuclear cells from both healthy volunteers and the CAEBV patient.3.Cytotoxic activity of induced CTLs using interferon gamma producing ability of CTLs :Then we examined the cytotoxic activities of induced CTLs. First we confirmed that BRLF1 tetramer specific CD8+ CTLs from healthy volunteers could produce interferon gamma only after BRLF1 specific peptides. We found that the mononuclear cells from a CAEBV patient also produce BRLF1 tetramer specific CTLs after stimulation with specific peptides. However, BRLF1 specific CTLs from the patient produced interferon gamma only approximately 30%, as compared with those from the healthy volunteers approximately 50%.These results indicated the possibility that mononuclear cells from both healthy volunteers and the CAEBV patients are able to induce and proliferate specific CTLs, but cytotoxic activities of specific CTLs from the patient is reduced as compared with those of healthy volunteers. To elucidate the mechanism of the reduced CTL-activity of the CAEBV patient will have great implications to understand the etiology of CAEBV and the CTL therapy. Less
我们检测了慢性活动性EBV感染(CAEBV)患者外周血CD 8+细胞中EB病毒(EBV)特异性细胞毒性T细胞的存在、EBV特异性CTL的诱导以及诱导的CTL的细胞毒性活性,结果如下:1.通过HLAA 24特异性和EBV-CTL证实EBV特异性CTL特异性四聚体分析在健康志愿者和传染性单核细胞增多症患者的外周血淋巴细胞中发现BRLF 1肽特异性CTL。2.抗原特异性CTL的诱导:以HLA A 24阳性的自体B类淋巴母细胞(B-LCL)为抗原提呈细胞,用B-LCL刺激外周血单个核细胞,用BRLF 1肽或不用BRLF 1肽刺激。即使在没有BRLF 1特异性肽的情况下,我们也能够成功地诱导BRLF 1四聚体阳性CTL。这表明, ...更多信息 h BRLF 1特异性刺激从EBV感染的B-LCL给予特异性CTL而无需进一步肽脉冲。在健康志愿者和CAEBV患者的单个核细胞中观察到这些CD 8阳性BRLF 1四聚体特异性诱导和增殖的CTL。3.利用CTL产生干扰素γ的能力检测诱导的CTL的细胞毒活性:然后检测诱导的CTL的细胞毒活性。首先,我们证实了来自健康志愿者的BRLF 1四聚体特异性CD 8 + CTL只能在BRLF 1特异性肽之后产生干扰素γ。我们发现来自CAEBV患者的单核细胞在用特异性肽刺激后也产生BRLF 1四聚体特异性CTL。结果表明,正常人和CAEBV患者外周血单个核细胞均能诱导增殖特异性CTL,但患者外周血特异性CTL的细胞毒活性较正常人低。阐明CAEBV患者CTL活性降低的机制,对了解CAEBV的病因和CTL治疗具有重要意义。少

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction
  • DOI:
    10.1016/j.ymthe.2004.08.008
  • 发表时间:
    2004-11-01
  • 期刊:
  • 影响因子:
    12.4
  • 作者:
    Dupré, L;Trifari, S;Roncarolo, MG
  • 通讯作者:
    Roncarolo, MG
Quality of Umbilical Cord Blood CD34+ Cells in a Double-Compartment Freezing Bag Cryopreserved without a Rate-Controlled Programmed Freezer
不使用速率控制程序冷冻机冷冻保存的双室冷冻袋中脐带血 CD34 细胞的质量
  • DOI:
    10.1532/ijh97.06147
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    M. Minegishi;Tsuneo Itoh;Narumi Fukawa;T. Kitaura;J. Miura;Hiroyuki Takahashi;Akira Suzuki;Yoshinori Kudo;Ayuko Narita;Yuko Sato;Masakuni Suzuki;Takanori Watanabe;Yuichi Wada;Y. Takeyama;S. Tsuchiya
  • 通讯作者:
    S. Tsuchiya
Phage ΦC31 integrase-mediated genomic integration of the common cytokine receptor gamma chain n human T-cells.
噬菌体 ΦC31 整合酶介导人类 T 细胞中常见细胞因子受体 γ 链的基因组整合。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ishikawa Y;Tanaka N;Murakami K;Uchiyama T;Kumaki S;Tsuchiya S;Kugoh H;Oshima M;Calos MP;Sugamura K
  • 通讯作者:
    Sugamura K
Characterization of a novel nonsense mutation in the interleukin-7 receptor α gene in a Korean patient with severe combined immunodeficiency
Phage ψC31 integrase-mediated genomic integration of the common cytokine receptor gamma chain n human T-cells.
噬菌体 ψC31 整合酶介导人类 T 细胞中常见细胞因子受体 γ 链的基因组整合。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ishikawa Y;Tanaka N;Murakami K;Uchiyama T;Kumaki S;Tsuchiya 5;Kugoh H;Oshima M;Calos MP;Sugamura K.
  • 通讯作者:
    Sugamura K.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUCHIYA Shigeru其他文献

TSUCHIYA Shigeru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUCHIYA Shigeru', 18)}}的其他基金

Homologous recombination-mediated gene correction in iPS cells o Ornithine transcarbamylase deficiency
iPS 细胞中同源重组介导的基因校正 o 鸟氨酸转氨甲酰酶缺陷
  • 批准号:
    23659511
  • 财政年份:
    2011
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Leukemogenesis due to insertional mutagenesis-a NOG mouse model-
插入突变引起的白血病发生-NOG小鼠模型-
  • 批准号:
    19390280
  • 财政年份:
    2007
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
GENE THERAPY FOR X-LINKED SEVERE COMBINED IMMUNODEFICIENCY DISEASE
X连锁严重联合免疫缺陷病的基因治疗
  • 批准号:
    14370240
  • 财政年份:
    2002
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
MECHANISM OF INFECTION OF EPSTEIN-BARR VIRUS TO T AND NK CELLS
EB病毒感染T细胞和NK细胞的机制
  • 批准号:
    12470165
  • 财政年份:
    2000
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
TARGET CELL SPECIFIC GENE TRANSFER BY ANTIFECTION AND REGULATION OF PROLIFERATION OF CANCER CELLS
通过抑制和调节癌细胞增殖进行靶细胞特异性基因转移
  • 批准号:
    10470173
  • 财政年份:
    1998
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Function of the gene of Wiskott-Aldrich syndrome
Wiskott-Aldrich 综合征基因的功能
  • 批准号:
    08457219
  • 财政年份:
    1996
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
PURIFICATION OF HEMATOPOIETIC STEM CELLS BY A CD117 MONOCLONAL ANTIBODY,MTK1, IN ORDER TO TRANSFECT HUMAN GENES-A PRELIMINARY STUDY
CD117单克隆抗体MTK1纯化造血干细胞转染人类基因的初步研究
  • 批准号:
    06454295
  • 财政年份:
    1994
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
ESTABLISHMENT AND CHARACTERIZATION OF AN IMMATURE MYELOID CELL LINE, M-MOK, GROWN IN THE PRESENCE OF FIBROBLAST-FEEDER CELLS
在成纤维细胞饲养细胞存在下生长的未成熟骨髓细胞系 M-MOK 的建立和表征
  • 批准号:
    03454260
  • 财政年份:
    1991
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Etiology of congenital agammaglobulinemia: Growth defect of precursor B lymphoblastoid cell lines and immunoglobulin gene rearrangements.
先天性无丙种球蛋白血症的病因:前体 B 淋巴母细胞系的生长缺陷和免疫球蛋白基因重排。
  • 批准号:
    62480224
  • 财政年份:
    1987
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了